Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2018 Sep 4;21(8):1894–1900. doi: 10.1038/s41436-018-0264-5

Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Amalia M Issa 1,2,3,✉, Adrian Thorogood 3, Yann Joly 3, Bartha M Knoppers 3
PMCID: PMC7608196  PMID: 30177852

Correction to: Genet Med advance online publication 10 July 2018; 10.1038/s41436-018-0099-0

In the original version of this Article, the affiliation details for Personalized Medicine & Targeted Therapeutics, USA were incorrectly given as Personalized Medicine & Targeted Therapeutics, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA. This has now been corrected in both the PDF and HTML versions of the Article.

Articles from Genetics in Medicine are provided here courtesy of Nature Publishing Group

RESOURCES